Ispecimen inc (ISPC) - News Archive

iSpecimen Inc. Charts a Promising Financial Course: Recent Public Offering and Strategic Developments Indicate Growth and StabilityiSpecimen Inc. Charts a Promising Financial Course: Recent Public Offering and Strategic...

iSpecimen Inc. Secures $1 Million Loan and Strengthens Leadership Amid Strategic Growth InitiativesIntroductionOn September 26, 2024, iSpecimen Inc. (Nasdaq: ISPC), a recognized player in the global marketplace for bios...

iSpecimen Announces 1-for-20 Reverse Stock Split Amid Growth Ambitions: Prepares to Share Full Year 2023 Financial ResultsWOBURN, Mass. Sept. 11, 2024nn iSpecimen Inc. (Nasdaq: ISPC), an online global marketplace that c...

iSpecimen Inc. (Nasdaq: ISPC), the pioneering online marketplace connecting scientists with healthcare specimen providers for research purposes, has announced that it will unveil its full year financial results for the...

iSpecimen, a leading supplier of human biospecimens, and TriMetis Life Sciences, a pioneer in digital AI histopathology services, have announced a strategic partnership aimed at revolutionizing tissue-based research. By...

In an endeavor to advance the field of oncology research, iSpecimen Inc has reinforced its global biospecimen offering by adding new suppliers and expanding existing relationships. This strategic move aims to provide re...